Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact email@example.com.
Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea
24 Pages Posted: 10 Mar 2020More...
Background: The pneumonia associated with the novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2) is breaking out in Wuhan, China. We aimed to clarify the differences of clinical, laboratory, radiological, and outcome characteristics between SARS-CoV-2 infective pneumonia (Corona Virus Disease 2019, COVID-19) patients with diarrhea and those without.
Methods: In this retrospective, single-center study, we included 84 confirmed patients of SARS-CoV-2 pneumonia in Wuhan Union Hospital from Jan 19 to Feb 7. Patients were confirmed by Real-Time Reverse-Transcriptase–Polymerase-Chain-Reaction Testing in pharyngeal swab. The clinical manifestations, laboratory examinations, imaging manifestations and outcomes of patients with diarrhea and those without diarrhea were compared.
Findings: Of 84 patients with SARS-CoV-2 pneumonia, diarrhea occurred in 26 (31%) patients. Patients with diarrhea, compared to those without diarrhea, were more likely to have headache (57.7% vs 22.4%, p = 0.003), myalgia or fatigue (94.4% vs 50.0%,p = 0.010), cough(84.6% vs 44.8%, p < 0.001), sputum production(53.8% vs 20.7%, p = 0.0004), nausea(38.5% vs 10.3, p < 0.005) and vomiting(19.2% vs 1.7%, p = 0.010). The duration of fever and dyspnea in patients with diarrhea was significantly longer than those without diarrhea (10.5±4.7 vs 7.6±3.4(day), p = 0.005; 8.1±3.2 vs 4.7±2.3(day), p = 0.002; respectively). There are no differences in most of the laboratory findings between these two groups, including lymphocyte count, creatinine, lactate dehydrogenase and D-Dimer. The positive rate of testing SARS-CoV-2 from stool of COVID-19 patients with diarrhea was much higher than that of patients without (69.2% vs 17.2%, p < 0.001). As of Feb 19, the negative rate in retesting SARS-CoV-2 from throat swab of diarrhea group was significantly lower, as compared with non-diarrhea group (76.9% vs 96.6%, p = 0.010). Of 76 COVID-19 patients whose throat swab test have turn to be negative for SARS-CoV-2, the positive rate in retesting SARS-CoV-2 from stool was significantly higher in diarrhea group, as compared to non-diarrhea group (45.0% vs 19.6%, p = 0.039).
Interpretation: COVID-19 patients with diarrhea suffered discomfort longer, as compared with COVID-19 pneumonia patients without diarrhea. The elimination of SARS-CoV-2 from digestive system took much more time than that from respiratory system, in some COVID-19 patients with diarrhea.
Funding Statement: The authors stated: "None."
Declaration of Interests: All authors declare no competing interests.
Ethics Approval Statement: Data collection and analysis of cases and close contacts were determined by the National Health Commission of the People’s Republic of China to be part of a continuing public health outbreak investigation and were thus considered exempt from institutional review board approval.
Keywords: SARS-Cov-2; COVID-19; diarrhea
Suggested Citation: Suggested Citation